Hält derzeit Positionen bei Spruce Biosciences Inc, Biomarin Pharmaceutical Inc, Mirati Therapeutics Inc and Horizon Therapeutics PLC
Position | Company | Period |
---|---|---|
Chairman of the Board | Spruce Biosciences Inc | 1. Januar 2016 - |
Independent Director | Biomarin Pharmaceutical Inc | 15. Dezember 2005 - |
Independent Director | Mirati Therapeutics Inc | 5. November 2014 - |
Lead Independent Director | Horizon Therapeutics PLC | 1. August 2012 - |
Independent Director | Horizon Therapeutics PLC | 1. September 2011 - 1. August 2012 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-06-09 | 2023-06-08 |
Mirum Pharmaceuticals Inc
(MIRM)
|
GV Geplanter Verkauf |
14.608
-100.0%
29,00423.632 USD |
14.608 -100.0% | 29,00 | 423.632 USD | |
2023-05-04 | 2023-05-03 |
Mirum Pharmaceuticals Inc
(MIRM)
|
GV Geplanter Verkauf |
14.608
-100.0%
28,00409.024 USD |
14.608 -100.0% | 28,00 | 409.024 USD | |
2021-07-23 | 2021-07-22 |
Horizon Therapeutics PLC
(HZNP)
|
GV Geplanter Verkauf |
4.000
-100.0%
100,05400.200 USD |
4.000 -100.0% | 100,05 | 400.200 USD | |
2021-07-23 | 2021-07-22 |
Horizon Therapeutics PLC
(HZNP)
|
GV Geplanter Verkauf |
1.000
-20.0%
100,00100.000 USD |
1.000 -20.0% | 100,00 | 100.000 USD | |
2021-03-09 | 2021-03-05 |
Biomarin Pharmaceutical Inc
(BMRN)
|
V Verkauf |
5.000
-10.5%
76,28381.400 USD |
5.000 -10.5% | 76,28 | 381.400 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
89
-2.0%
249,4222.198 USD |
89 -2.0% | 249,42 | 22.198 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
1.019
-19.0%
248,55253.269 USD |
1.019 -19.0% | 248,55 | 253.269 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
1.997
-27.1%
247,62494.502 USD |
1.997 -27.1% | 247,62 | 494.502 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
1.807
-19.7%
246,73445.834 USD |
1.807 -19.7% | 246,73 | 445.834 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
1.284
-12.3%
245,11314.725 USD |
1.284 -12.3% | 245,11 | 314.725 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
1.653
-13.7%
244,45404.083 USD |
1.653 -13.7% | 244,45 | 404.083 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
1.815
-13.0%
243,35441.671 USD |
1.815 -13.0% | 243,35 | 441.671 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
857
-5.8%
242,29207.641 USD |
857 -5.8% | 242,29 | 207.641 USD | |
2020-12-16 | 2020-12-14 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
379
-2.5%
241,2291.422 USD |
379 -2.5% | 241,22 | 91.422 USD | |
2020-08-07 | 2020-08-05 |
Horizon Therapeutics PLC
(HZNP)
|
GV Geplanter Verkauf |
1.755
-100.0%
73,35128.729 USD |
1.755 -100.0% | 73,35 | 128.729 USD | |
2020-08-05 | 2020-08-03 |
Biomarin Pharmaceutical Inc
(BMRN)
|
GV Geplanter Verkauf |
2.500
-5.5%
120,35300.875 USD |
2.500 -5.5% | 120,35 | 300.875 USD | |
2020-07-22 | 2020-07-22 |
Horizon Therapeutics PLC
(HZNP)
|
GV Geplanter Verkauf |
1.755
-100.0%
60,00105.300 USD |
1.755 -100.0% | 60,00 | 105.300 USD | |
2020-06-26 | 2020-06-25 |
Horizon Therapeutics PLC
(HZNP)
|
GV Geplanter Verkauf |
1.755
-100.0%
55,0096.525 USD |
1.755 -100.0% | 55,00 | 96.525 USD | |
2020-05-26 | 2020-05-22 |
Horizon Therapeutics PLC
(HZNP)
|
V Verkauf |
10.530
-100.0%
48,77513.505 USD |
10.530 -100.0% | 48,77 | 513.505 USD | |
2019-11-14 | 2019-11-12 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
3.042
-57.4%
102,44311.622 USD |
3.042 -57.4% | 102,44 | 311.622 USD | |
2019-05-15 | 2019-05-13 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
300
-18.3%
66,0819.825 USD |
300 -18.3% | 66,08 | 19.825 USD | |
2019-05-15 | 2019-05-13 |
Mirati Therapeutics Inc
(MRTX)
|
GV Geplanter Verkauf |
5.460
-76.9%
65,26356.314 USD |
5.460 -76.9% | 65,26 | 356.314 USD | |
2016-02-23 | 2016-02-22 |
Biomarin Pharmaceutical Inc
(BMRN)
|
GV Geplanter Verkauf |
7.500
-22.2%
80,00600.000 USD |
7.500 -22.2% | 80,00 | 600.000 USD |